KMD Brands’ hugely discounted equity raise, ANZ’s confidence survey drop, and house price doldrums indicate a difficult path forward.
Continued ownership of offshore Taranaki oil and gas asset to be assessed.
Numbers low as government retains control of managed isolation process.
Ralph Highnam blames shareprice fall on enduring uncertainty, especially in the US.
The company has more than $2 billion in bank debt.
US approval of bladder cancer test sees results heading in the right direction.
NZ Algae Innovations investigates the viability of large-scale NZ production of Tahi Spirulina.
Long saga nears end with overwhelming vote in favour of scheme.
Shareholders register protest votes against directors up for re-election.
New Tower boss talks up potential after removing sizeable legacy risk.